Business Description
Intellia Therapeutics is a Cambridge, Massachusetts-based company founded in 2014 that develops treatments designed to permanently correct disease-causing genetic errors in the human body. Its own pipeline includes two early-stage clinical programs targeting rare conditions ? a protein-buildup disorder affecting the heart and nerves, and a condition that causes severe recurring swelling. Beyond its internal work, Intellia partners with several biotechnology companies to advance a range of cell-based therapies for cancer, autoimmune diseases, and cystic fibrosis.
